Adjuvant development program
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93018C00044
- Awardee
-
Vaxine PTY LTD UEI Z9AUC2SNX5A4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,690,025
Award facts
- Opportunity
-
- HHSNIHNIAIDBAA20171 Solicitation number
- Contract value 100% obligated
- $6,690,024.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 17 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Australia
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,551,986 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,170,507 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,473,199 | |
| Original award | $2,494,333 |
Show all 12
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $6,690,024.90 definitive, cost-no-fee contract to Vaxine PTY LTD, a for-profit organization located in Australia, for an Adjuvant Development Program. The contract, which has an ultimate completion date of February 10, 2025, was awarded on September 10, 2018 and does not have a set-aside designation. The contract aims to support the development of vaccine adjuvants, which are compounds that enhance the immune response to a vaccine. This contract is not associated with a larger contract vehicle.
Quick answers
Who was awarded contract 75N93018C00044?
75N93018C00044 was awarded to Vaxine PTY LTD by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 10, 2018.
How much is contract 75N93018C00044 worth?
The government has obligated $6,690,025 on 75N93018C00044.
Was contract 75N93018C00044 competed?
The extent of competition for 75N93018C00044 was full and open competition. The government received 17 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award